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Introduction 
The etiology of and pathophysiology surrounding the long-
accepted and studied female gender advantage in coronary 
heart disease (CHD) remains poorly understood. Numerous 
studies have characterized the significant gender differences 
with regards to the incidence and rate of development of ath-
erosclerosis and the resulting morbidity and mortality associ-
ated with almost any degree of vascular compromise. Despite 
numerous studies quantifying and attempting to explain the 
female advantage in the development of CHD, the explana-
tion for this advantage remains elusive. Differences between 
men and women in the presentation, diagnosis, assessment, as 
well as prognosis of cardiovascular disease are evident and have 
prompted a worldwide campaign to redefine cardiovascular 
disease as a female as well as male disease and to structure 
treatment guidelines specifically for women.
Recent population data in the United States indicates that 
despite an aging population and the obesity epidemic currently 
plaguing the country, the mortality associated with CHD has 
decreased in women from one in three to one in four.1 This 
is likely at least partially a result of an increasing focus on 
cardiac disease as not only a male disease. In fact, while often 
underappreciated, cardiovascular disease is the leading cause 
of death in women, far exceeding cancer and infectious causes. 
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Supplementary Issue: Cardiovascular Imaging: Current Developments in Research and Clinical Practice
AbstrAct
bAckground: Arterial calcium as measured by 64-slice computed tomography coronary angiography (64-CT) is a reliable predictor of cardiovascular 
disease risk. Lipid-rich plaques with lower degrees of calcification may pose greater risk for adverse coronary events than more stabilized calcified plaques as 
a result of the increased risk of plaque rupture, migration, and subsequent acute coronary syndrome. We sought to examine coronary artery calcium scores 
as measured via 64-CT to assess the extent of calcification and plaque distribution in women compared to men.
Methods: A total of 138 patients referred for 64-CT were evaluated. Computerized tomographic angiography was performed using the GE LightSpeed 
VCT. Subgroup analysis comparing male and female data (including demographic data) was performed. All major coronary arteries were analyzed for coronary 
stenosis/plaque characterization as well as total vessel calcium (Agatston) score quantification. Patient demographics and coronary risk factors were recorded.
results: A total of 552 coronary arteries were evaluated in 138 patients (85 men, 53 women). The average age for females was 64.4 ± 10.8 years and for 
males 60.0 ± 12.8 years. The only demographic/cardiovascular risk factor in which the difference between men and women was significant was smoking his-
tory, where 23.5% of men had a history of smoking while only 9.6% of females endorsed having a smoking history (P , 0.044). On comparison of all total 
vessel calcium scores, males had a higher total mean calcium score than females in each individual vessel. The results were as follows for males versus females, 
respectively: left main total vessel calcium score 46.49 versus 16.71 (P = 0.167); left anterior descending 265.21 versus 109.6 (P , 0.003); left circumflex 
130.5 versus 39.7 (P , 0.004); and right coronary 213.5 versus 73.8 (P , 0.01). The odds of having a total calcium score .100 (versus not) was 3.62 times 
greater in males relative to females, given that all the other cardiovascular risk factors are adjusted for (95% confidence interval: 1.37–9.54). On average, men 
had an average of 2.1 ± 1.5 epicardial vessels with a calcium score $11 compared to 1.3 ± 1.4 for women (P , 0.005).
conclusIon: There are clear differences between males and females regarding total vessel calcium scores and therefore risk of future adverse coronary 
events. Males tended to have higher average calcium scores in each coronary artery than females with a greater tendency to have multiple vessel involvement. 
Using this information, more large-scale, randomized controlled studies should be performed to correlate differences in the extent of coronary calcification 
with the observed variance in clinical presentation during coronary events between males and females as a means to potentially establish gender-specific 
therapeutic regimens.
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Along with the increasing focus on cardiovascular disease as 
a cause of significant morbidity and mortality in women have 
come increasing observational studies and case series delineat-
ing the significant differences in almost every aspect of cardiac 
disease between males and females. While large, randomized 
controlled studies in the past focused on cardiovascular disease 
primarily in male subjects, recent large-scale cardiac trials in 
women have prompted the development of evidence-based 
guidelines for CHD diagnosis and management in women.
The development of new means of noninvasive cardiac 
imaging, particularly cardiac computerized tomographic 
angiography (CTA; 64-CT) allows more extensive analysis of 
the presence and nature of intra-arterial plaques. The pres-
ence and degree of intracoronary calcification has been shown 
to correlate with the degree of atherosclerosis.1 The utility 
of CTA in predicting risk of adverse cardiovascular disease 
events has been demonstrated in numerous studies. Few stud-
ies, however, have utilized this relatively new technology 
to shed light upon the significant gender differences in the 
long-term development of intra-arterial plaques. CTA allows 
for the description, both quantitatively and qualitatively, of a 
lesion’s area, peak density, and mean density, enabling com-
mentary regarding the composition (calcified as opposed to 
lipid-laden, for example) of each intra-arterial lesion. Given 
the long-acknowledged disparity between males and females 
when it comes to cardiac disease, more studies are acknowledg-
ing these differences and attempting to explain the observed 
variations. This has led to more stringent recommendations 
regarding the approach to treatment of cardiac disease, partic-
ularly in postmenopausal women where there has been signifi-
cant debate regarding the utility (or lack thereof) of hormone 
replacement therapy and the use of vitamins and antioxidants. 
In order to attempt to further investigate the observed differ-
ences between genders, we sought to use cardiac CT (Agat-
ston method of quantification),2 which has revolutionized the 
noninvasive visualization and quantification of intracoronary 
plaque burden over the past decade, to compare the pattern 
and incidence of disease in males and females. A more exten-
sive understanding of differences in the development, severity, 
and distribution of coronary disease in males and females may 
shed light on a still elusive subject.
Methods
Data collected from 138 consecutive patients referred for 
64-CT at our institution was evaluated. CTA was performed 
using the General Electric LightSpeed VCT (GE Healthcare). 
Data were analyzed in a retrospective fashion after the insti-
tutional review board granted an exemption from the require-
ment for approval. The exemption was granted as the research 
involved study of existing, de-identified data. Subgroup analy-
sis comparing male and female data was performed. The four 
major coronary arteries were analyzed for the presence of cal-
cified coronary stenosis/plaque as according to the total vessel 
calcium (Agatston) score quantification. Vessels analyzed were 
the left main (LM) coronary artery, the left anterior descend-
ing (LAD), the left circumflex (LCX), and the right coronary 
artery (RCA). Patient demographics and coronary risk factors 
including diabetes mellitus, hypertension, smoking history, 
and dyslipidemia were recorded.
In order to be included in the study, patients must have 
been at least 18 years of age. Patients underwent 64-slice 
CT coronary angiography using the GE LightSpeed VCT. 
Patients on whom no background information (demographic 
data, medical history/risk factors) was recorded in the CTA 
database were excluded from data analysis.
statistical analysis. Based on the scores on calcium scor-
ing of the LM, LAD, LCX, and RCA, the number of vessels 
with a calcium score .11 and the number of vessels with lesions 
101–400 were categorized. These two variables were also ana-
lyzed to determine if they were associated with gender using 
the Fisher’s exact test. A result was considered to be statisti-
cally significant when two-tailed P was ,0.05. Patients were 
classified into two groups: with “significant” disease or without 
“significant” disease. A subject was classified as having signifi-
cant disease if his/her total calcium score exceeds 100 HU (as 
described above). Univariable comparisons of continuous vari-
ables were carried out using either the t-test or Mann–Whitney 
test, as appropriate; for categorical variables, either the chi-
square test or Fisher’s exact test was used, as appropriate.
Logistic regression analysis was carried out with “sig-
nificant disease” as the “event” of interest using the following 
explanatory variables in the model: gender, age, body mass 
index (BMI), smoking status, hypertension, hypercholester-
olemia and diabetes, as well as the interaction effects of gen-
der and each of diabetes and smoking (gender × diabetes and 
gender × smoking interaction).
In order to arrive at a more parsimonious model, a back-
ward selection algorithm was applied in order to determine 
which factors were most significantly associated with signifi-
cant disease. Adjusted odds ratios are presented along with the 
corresponding 95% confidence intervals. All analyses were gen-
erated using SAS 9.3 (SAS Institute Inc., Cary, NC, USA).
results
A total of 552 coronary arteries were evaluated in 138 patients 
(85 men, 53 women). Baseline demographic and risk factor 
data is presented in Table 1. The average age for males was 
60.0 ± 12.8 years and for the females, 64.4 ± 10.8 years. Males 
had an average BMI of 29.5 ± 5.2 kg/m2 while for females it 
was 28.5 ± 5.3 kg/m2. The only demographic/cardiovascular 
risk factor in which the difference between men and women 
was significant was smoking history, where 23.5% of men had 
a history of smoking while only 9.6% of females endorsed hav-
ing a smoking history (P = 0.04). The differences between men 
and women in terms of the other demographic data were not 
significant (Table 1).
On comparison of all total vessel calcium scores (Table 2), 
males had a higher total mean calcium score than females in 
Gender differences in coronary calcification on CTA
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each individual vessel. The results were as follows for males ver-
sus females, respectively: LM total vessel calcium score 46.49 
versus 16.71 (P = 0.167); left anterior descending 265.21 versus 
109.6 (P , 0.003); LCX 130.5 versus 39.7 (P , 0.004); right 
coronary 213.5 versus 73.8 (P , 0.01). The odds of having a 
total calcium score .100 (versus not) were 3.62 times greater in 
males relative to females, given that all the other cardiovascular 
risk factors are adjusted for (95% confidence interval [CI]: 
1.37–9.54). On average, men had a mean of 2.1 ± 1.5 epicar-
dial vessels with a calcium score $11 compared to 1.3 ± 1.4 
for women (P , 0.005). Using a calcium score $101, men 
had an average of 1.2 ± 1.4 epicardial vessels involved while 
women had 0.67 ± 1.0 (P , 0.036).
discussion
The marked gender differences in the presentation, diagnosis, 
and management of cardiovascular disease have been estab-
lished by numerous studies over the past half-century.3–6 Pre-
menopausal women in particular have significantly lower rates 
of cardiovascular disease compared to age-matched males. The 
explanation behind acknowledged differences between men 
and women when it comes to cardiovascular disease remains 
elusive, however. Numerous theories attempting to explain 
these differences have been posited over the past 50 years. Nev-
ertheless, no single unifying explanation can account for the 
gender gap. The cause of these observed differences is likely an 
amalgam of numerous variables, which have each been shown 
to individually contribute to observed variations including dif-
ferences in vascular beds, hormonal factors, as well as lifestyle 
issues. Our study indicates that in addition to the differences 
already described, there are stark dissimilarities between men 
and women in the composition, distribution, and location of 
intracoronary lesions which may explain some of the observed 
variations in clinical presentation, sequelae, and outcomes.
The hormonal differences between males and females, 
particularly premenopausal females who appear to have a 
significant protective factor, have always been at the root of 
comparisons in the rate of cardiovascular disease between 
the genders. In the past five years, however, reports of the 
Women’s Health Initiative and the Heart and Estrogen/
Progestin Replacement Study have indicated that combination 
hormone therapy is actually associated with an increased risk of 
CVD events in postmenopausal women, which seemed some-
what counterintuitive considering the theories that the female 
hormones estrogen and progesterone were cardioprotective.7–10 
These studies underscore the complicated nature of gender 
difference and cardiovascular disease. Epidemiological data 
indicate that compared with age-matched males, premeno-
pausal females have a decreased incidence of virtually all types 
of cardiovascular diseases, including coronary artery disease 
(CAD), hypertension, and potentially harmful cardiac struc-
tural remodeling such as left ventricular hypertrophy. These 
differences translate into a significant female advantage in 
the rates of mortality from cardiovascular disease, with male 
death rates from CHD ranging from 2.5 to 4.5 times that of 
females across populations in different countries, with differ-
ent lifestyles, and with variable population cardiovascular dis-
ease rates.11 The incidence of CHD in postmenopausal females 
does increase significantly and in fact surpasses that of men as 
demonstrated by the Framingham data.12,13
Gender dimorphism has been observed in nearly all 
aspects of cardiovascular disease, from hypertension to car-
diac remodeling to outcomes following percutaneous coronary 
intervention for acute myocardial infarction. Animal models 
have implicated a significant role for various estrogen recep-
tors in the development of CHD and cardiac remodeling.14 In 
addition, these hormones have even been implicated in rates of 
hypertension. While sex hormones have been hypothesized to 
contribute to the gender difference in blood pressure regula-
tion,15 it is more likely that androgens and not estrogens are pri-
marily responsible since androgens are known to increase blood 
pressure, whereas studies on hormone replacement therapy 
show essentially no effect on blood pressure in postmenopausal 
women.16 Studies indicate that the increase in serum testoster-
one in postmenopausal women may result in increased risk 
of hypertension and cardiovascular disease in these women.16 
Table 1. Baseline characteristics and cardiovascular disease risk 
factors.
MALES  
(n = 85)
fEMALES  
(n = 53)
P vALUE
age (years) 60.0 ± 12.8 64.4 ± 10.8 0.05 (ns)
BMi (kg/m2) 29.5 ± 5.2 28.5 ± 5.3 0.26 (ns)
hypertension 49 (57.6%) 33 (63.5%) 0.59 (ns)
dyslipidemia 53 (62.4%) 33 (63.5%) 1.00 (ns)
smoking history 20 (23.5) 5 (9.6) 0.04 (s)
Table 2. Comparison of mean coronary artery calcium score based 
upon gender.
vESSEL MALES
(n = 85)
fEMALES
(n = 53)
P vALUE
lM 46.5 ± 142.9;
(0; 0–1,094)
16.7 ± 56.5;
(0; 0–358)
,0.167 (ns)
lad 265.2 ± 395.2;
(88; 0–2,203)
109.56 ± 187.8;
(12; 0–989)
,0.003 (s)
lCX 130.5 ± 305.9;
(14; 0–1,993)
39.7 ± 115.6;
(0; 0–667)
,0.004 (s)
rCa 213.5 ± 364.9;
(14; 0–1,455)
73.79 ± 166.8;
(0; 0–806)
,0.010 (s)
total vessel  
calcium score
655.7 ± 1,037.5;
(154; 0–6,001)
239.71 ± 476.9;
(47.50; 0–2,820)
,0.003 (s)
number of  
vessels $11
2.1 ± 1.5;
(2; 0–4)
1.3 ± 1.4;
(1; 0–4)
,0.005 (s)
number of 
vessels .101
1.2 ± 1.4;
(1; 0–4)
0.67 ± 1.0;
(0; 0–4)
,0.036 (s)
Abbreviations: M, left main coronary artery; ns, nonsignificant; s, significant.
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Physiological changes associated with menopause affect several 
biochemical pathways, including lipid metabolism, resulting 
in a tendency toward elevated total cholesterol, triglycerides, 
and low-density lipoprotein cholesterol.17,18 Postmenopausal 
changes also result in enhanced activation of the coagulation 
pathway with elevated serum levels of plasminogen activator 
inhibitor-1 as well as fibrinogen.19,20 Further enhancing the 
risk of cardiovascular disease in postmenopausal women is 
impaired coronary artery vasoelasticity as well as increased 
endothelial dysfunction.21 Thus, postmenopausal women have 
numerous prothrombotic, atherogenic stimuli for the develop-
ment of cardiovascular disease.
Prior to the recent development of noninvasive cardiac 
imaging, it was difficult to characterize the nature of intra-
coronary arterial plaques. Using 64-CT coronary angiogra-
phy allows characterization of the degree of calcification of 
observed lesions and perhaps the likelihood of atheroscle-
rotic plaque rupture and vascular stenosis potentially leading 
to myocardial ischemia or infarction. The ability of CTA to 
characterize atherosclerotic plaque burden has been shown to 
be nearly as accurate as intravascular ultrasound.22,23 While 
the main goal of CTA is not to identify potentially vulner-
able plaques, lipid-laden plaques with the potential to rupture 
can be a clinical guide as seen on CTA.24 CTA is capable 
of detecting calcified or mixed plaques with sensitivities and 
specificities of approximately 90%. The ability to detect lipid-
laden, noncalcified plaques is not as good, however, with sen-
sitivities/specificities between 60% and 80%.22,25
Our data indicate that men have a significantly higher aver-
age calcium score across all major coronary vessels, despite simi-
larities in the age range and rate of the various major independent 
cardiovascular disease risk factors. Even after adjusting for smok-
ing (the only variable in which there was a statistically significant 
difference), males were still 3.62 times more likely to have a total 
vessel calcium score greater than 100 (95% CI: 1.37–9.54). In 
addition to higher overall calcium scores, men also tended to 
have a greater number of significant calcium scores (101–400), 
indicating a high likelihood of a stenotic lesion. This may shed 
light on the inconsistency that despite markedly higher calcium 
scores in most coronary arteries, the rate of CHD between post-
menopausal females and males of similar age are comparable 
and even higher in women according to some data.
The differences demonstrated by our CT data indicate 
that males have a higher incidence of significant plaque cal-
cification possibly resulting in some degree of flow limitation 
while females have significantly lower scores in each coronary 
vessel except for the LM coronary artery (Figure 1). In the 
LAD, LCX, and RCA, the males had a statistically significant 
higher measured calcium score in each vessel. The fact that 
postmenopausal women still have similar rates of CHD indi-
cates that the plaques seen on CTA in women may in fact, be 
more lipid-laden and therefore less stable than those observed 
in males. As a result, the mechanisms resulting in the variety 
of cardiovascular disease events such as stable/unstable angina 
and myocardial infarction may vary somewhat between males 
and females. Acute coronary syndromes most often result from 
disruption of intra-arterial coronary plaques resulting in throm-
bus formation, migration, and vessel occlusion. Large plaques 
that limit coronary artery flow (particularly under stress) as 
well as unstable, less calcified plaques have a greater likelihood 
of rupture and thrombus formation. The implications of this 
are significant for the utility of coronary CTA in predicting the 
risk of cardiovascular disease events based solely upon calcium 
scoring. The published data from the Multi-Ethnic Study of 
Atherosclerosis trial demonstrated the significantly higher risk 
of CAD events among patients with a calcium score between 
1 and 10 compared to those with a calcium score of 0 (hazard 
ration 3.23, 95% CI 1.17–8.95).26 Data from this large-scale 
study also indicated that approximately 16% of coronary arteries 
with significant stenosis on conventional invasive angiography 
had no calcification on 64-CTA.27 The trend seen in this study 
cohort of 6,110 individuals showed that men had higher cal-
cium scores than women, and the amount and prevalence of cal-
cium increased steadily with age. Almost two-thirds of women 
(62%) had calcium scores of zero in this sample, as opposed 
to 40% of men.26,27 While these findings show that calcifica-
tion differences exist, further studies have demonstrated that 
microvascular dysfunction gender variations exist28 and may 
explain differences in outcome in stable patients and in patients 
who present with acute coronary syndromes.29
According to our data, males have significantly larger, more 
calcified plaques than females, who had smaller, significantly less 
calcified lesions. The differences in plaque characteristics may 
be a clue as to variations in the presentation of acute coronary 
syndrome (ACS) in females compared to males. In addition, the 
previously described factors used to explain gender differences in 
cardiovascular disease such as hormonal variations, differences 
in vascular beds, and lifestyle issues likely contribute to the dif-
ferences observed in plaque characteristics. Given the differences 
in observed plaque characteristics, more studies should be per-
formed to analyze weather a different approach to medical ther-
apy (such as more aggressive lipid-lowering therapy) in women 
with suspected or proven cardiovascular disease is warranted.
study limitations
A drawback of our analysis is the selection bias of refer-
ring only low-risk patients to undergo coronary CTA and 
referring higher risk patients directly to coronary angiography. 
Although this may be a prudent means of evaluating and treat-
ing patients, it limits the assessment of the accuracy CTA for 
the detection of CAD and introduces a select set of patients 
for analysis which may lead to confounding factors. The pres-
ent study was also limited to small numbers of patients in a 
single center who underwent CTA and while the age of these 
patients was known and can be surmised in many cases, the 
menopausal status of the women was not available in this 
study. Finally, all the baseline medications that each patient 
was taking were not readily available, however, all these were 
Gender differences in coronary calcification on CTA
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patients closely followed by their referring physicians and pre-
sumably taking their required medication regimen.
conclusion
The observed differences between the sexes in cardiovascular 
disease are likely the result of a variety of biologic/genetic, envi-
ronmental, and behavioral factors. Noninvasive cardiac imag-
ing can potentially shed light on these differences by describing 
intra-arterial lesions both quantitatively and qualitatively. Our 
study indicates that among males and females with comparable 
age and presence of cardiovascular disease risk factors, males 
tend to have significantly higher intra-arterial coronary calcium 
scores than females in most coronary arteries. Since postmeno-
pausal females have an equal if not higher risk of developing 
cardiovascular disease as males, the mechanisms underlying the 
development of angina and myocardial infarction, for example, 
may, at least partially, be different according to gender. Differ-
ences in the composition of intra-arterial coronary lesions may 
explain why men and women present with cardiovascular dis-
ease sequelae and why outcomes may vary according to gender. 
More prospective studies correlating coronary plaque characte-
ristics and long-term outcomes in patients deemed to be at risk 
for coronary disease should be performed to optimize therapy 
based upon all patient characteristics, including gender.
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64-CT image from a male with less
diffuse, more focal flow-limiting
calcification in the RCA.
64-CT image from a female with
diffuse, RCA calcification with no
significant flow-limiting lesions.
figure 1. Comparison images of coronary plaque distribution between 
males and females.
